Views 72
Citations 0
Invited Commentary
October 13, 2016

Future Research Using Amblyopia Treatment Dose Monitors

Author Affiliations
  • 1Jaeb Center for Health Research, Tampa, Florida

Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Ophthalmol. Published online October 13, 2016. doi:10.1001/jamaophthalmol.2016.3791

In this issue of JAMA Ophthalmology, Maconachie et al1 present the results of their study in which they objectively evaluate compliance with optical correction as treatment for amblyopia through the use of a “glasses dose monitor.” Compliance with prescribed patching following the period of optical treatment was also evaluated through the use of an “occlusion dose monitor” (ODM). Their study highlights the importance of future research using dose monitors that could make it possible for clinicians to develop individualized patient-specific treatment plans to reduce the burden of amblyopia treatment on the child and family.

First Page Preview View Large
First page PDF preview
First page PDF preview